7Cole SP, Sparks KE, Fraser K, et al. Pharmacological characterization of multidrug resistance MRP-transfected human tumor cells[J]. Cancer Res,1994,54: 5902-5904.
8Armstrong RN. Structure, catalytic mechanism and evolution of the glutathione transferase[J]. Chem Res Toxico, 1997,10:2-5.
9Nooter K,Stoter G. Moleculer mechanisms of multidrug resistance in cancer chemotherapy[J]. Pathol Res Pract, 1996, 192(7) :768-780.
10Koshiyama M,Fujii H,Kinezaki M,et al. Correlation between TOPO- Ⅱ alpha expression and chemosensitivity testing for TOPO- Ⅱ -targeting drug in gynaecological carcinomas[J]. Anticancer Res, 2001,21(2A) :905-910.
3McCoy C, McGee SB, Cornwell MM. The Wilms' tumor suppressor,WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter. Cell Growth Differ, 1999, 10: 377-386.
4Hirose M. The role of Wilms' tumor genes. J Med Invest, 1999, 46:130-140.
5Bartsevich VV, Juliano RL. Regulation of the MDR1 gene by transcriptional repressors selected using peptide combinatorial libraries.Mol Pharmacol, 2000 , 58: 1-10.
6Frick DN, Richardson CC. DNA PRIMASES. Biochem, 2001,70:39-80.
7Zhao Y, You H, Liu F, et al. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett, 2002, 185: 211.
8Fan W, Wang Z, Kyzysztof F, et al. A new zinc ribbon gene (ZNRD1)is cloned from the human MHC class Ⅰ region. Genomics, 2000, 63:139-141.
9Chen HT, Legault P, Glushka J, et al. Structure of a (Cys3His) zinc ribbon, a ubiquitous motif in archaeal and eucaryal transcription. Protein Sci, 2000, 9: 1743-1752.
10Hem ming SA, Jansma DB, Macgregor PF, et al. RNA polymerase Ⅱ subunit Rpb9 regulates transcription elongation in vivo. J Biol Chem,2000, 275: 35506-35511.
